Effects of surface functionalization and size of MXene-based quantum dots on their optical properties: the exciton confinement matters
Nanoscale · 2025 · 17 (42) · 24529-24540
DOI: 10.1039/d5nr03127c ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Barbora Vénosová und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Faculty of Science, University of Ostrava, 30. dubna 22, 7013 Ostrava, Czech Republic. frantisek.karlicky@osu.cz. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: European Commission, Ministerstvo Školství, Mládeže a Tělovýchovy.
Abstract (Originalsprache)
Quantum confinement in MXene quantum dots enhances excitonic effects, causing a blue shift of the first optical transition. Surface functionalization allows for fine tuning of exciton character and spectral behavior into desirable features.
Autor:innen und Institutionen
- Department of Physics, Faculty of Science, University of Ostrava, 30. dubna 22, 7013 Ostrava, Czech Republic. frantisek.karlicky@osu.cz.
Förderung
- European Commission
- Ministerstvo Školství, Mládeže a Tělovýchovy
Zitieren
APA
Vénosová, B., & Karlický, F. (2025). Effects of surface functionalization and size of MXene-based quantum dots on their optical properties: the exciton confinement matters. Nanoscale, 17(42), 24529-24540. https://doi.org/10.1039/d5nr03127c
Vancouver
Vénosová B, Karlický F. Effects of surface functionalization and size of MXene-based quantum dots on their optical properties: the exciton confinement matters. Nanoscale. 2025;17(42):24529-24540. doi:10.1039/d5nr03127c
BibTeX
@article{Vnosov2025,
author = {Vénosová, Barbora and Karlický, František},
title = {Effects of surface functionalization and size of MXene-based quantum dots on their optical properties: the exciton confinement matters},
journal = {Nanoscale},
year = {2025},
volume = {17},
number = {42},
pages = {24529--24540},
doi = {10.1039/d5nr03127c}
}
EUVIMED